Skip to content

Supernormal Oxygen Delivery for Elderly Surgical Patients

A Randomized Controlled Study of Supernormal Oxygen Delivery Goal-directed Therapy for Elderly Patients Undergoing Proximal Femoral Surgery.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02629250
Acronym
SNODES
Enrollment
70
Registered
2015-12-14
Start date
2015-12-31
Completion date
2017-03-31
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Fractures

Keywords

proximal femoral fracture, goal-directed therapy, myocardial injury, supernormal oxygen delivery, elders, stroke volume maximization

Brief summary

Elderly patients with poor cardiopulmonary reserve tend to suffer higher risk and develop more complications following major surgery. Quite a few researches have shown the benefits of goal-directed therapy (GDT) using fluid loading or inotropic agents or both to improve outcome during major surgery. However there is concern that inotropic therapy for a supernormal oxygen delivery (DO2I) may lead to an increased incidence of myocardial ischemia. Even though the meta-analysis has stated that DO2I strategy could possibly reduce the incidence of cardiac complication than stroke volume optimization strategy, there are very few evidence available in the literature regarding the effect on myocardial ischemia in surgical patients, especially in non-cardiac surgical patients. This study is undertaken to test the hypothesis that an intraoperative DO2I optimization result in a decreased myocardial ischemia in the elderly high-risk surgical patients.

Detailed description

Elderly patients with poor cardiopulmonary reserve tend to suffer higher risk and develop more complications following major surgery \[1\]. Quite a few researches have shown the benefits of goal-directed therapy(GDT) using fluid loading or inotropic agents or both to improve outcome during major surgery \[2-7\]. The maintenance of adequate tissue perfusion and global oxygen delivery (DO2I) is essential to maintain adequate tissue perfusion and oxygenation in relation to increased metabolic demand during high risk surgery. However, there is concern that inotropic therapy for a supernormal oxygen delivery may lead to an increased incidence of myocardial ischemia \[8\]. Even though the meta-analysis has stated that DO2I optimization could possibly reduce the incidence of cardiac complication than stroke volume optimization strategy \[9\],there are very few evidence available in the literature regarding the effect on myocardial ischemia in surgical patients, especially in non-cardiac surgical patients. This study is undertaken to test the hypothesis that an intraoperative DO2I optimization result in a decreased myocardial ischemia in the elderly high-risk surgical patients. The investigators will conduct a prospective, randomized, controlled, double-blinded trial in seventy patients who scheduled for proximal femur surgery under General anesthesia following nerve block. Both the patients will be allocated to one of two equal groups to receive either intraoperative fluid regimen guided by SV strategy or DO2I strategy. In the control(SV) group, the patients will receive an intravenous infusion of 250 ml Ringer's lactate solution in 5 min as a fluid challenge for stroke volume maximization. In the experimental(DO2I) group, fluid and dobutamine will be given to reach a stroke volume maximization and supernormal oxygen delivery. The primary outcome is preoperative and 24h postoperative serum concentration of troponin T. Secondary outcomes include the incidence of tachycardia, arrhythmia, myocardial infarction, pneumonedema and acute heart failure, blood pressure, pulmonary infection, fluid volume, blood transfusion volume, renal function, PONV, Length of postoperative hospital stay and mortality. Data will be collected and recorded by the clinical teams who are blind to study arm allocation.

Interventions

When SpO2 ≥92%, mean arterial pressure (MAP) 65-100 mmHg, HR \<100 bpm, Hb \>8mg/dL and temperature ≥36℃, the patients will receive a 250 ml Ringer's lactate solution in 5 min as a fluid challenge for stroke volume (SV) maximization. The fluid challenge will repeat until the SV failed to increase by a factor of 10%. A reassessment on the SV maximization will be taken every 30 minutes and to restart algorithm when increased SV \>10% or blood loss \>250ml. Blood transfusions will be used to maintain a hemoglobin concentration over 8mg/dL.

PROCEDUREsupernormal DO2

Goal directed fluid therapy is administrated as group SV maximization. Then DO2I will be assessed. If at this stage the DO2I can not be greater than 600 mL/m2 (supernormal oxygen delivery goal), then dobutamine will be started at a dose of 2.5 μg/kg/min and increased by the same increment every 20 minutes until the described target is reached or until a maximal dose of 20 μg/kg/min is given. Dobutamine is decreased in dose or discontinued if the heart rate is above 100 beats per minute or shows signs of cardiac ischemia.

Sponsors

Guangzhou First People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients scheduled for proximal femur fracture (PFF) surgery at this institution 2. American Society of Anaesthesiologists (ASA) physical status of III or VI 3. Two or more risk factors according to risk index of Lee

Exclusion criteria

1. Patient age \< 70 yrs 2. Ongoing myocardial infarct or ischemia 3. Chronic haemodialysis 4. Inability to cooperate in the study 5. Patient refusal

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in concentration of troponin T at 24 hours postoperativelypreoperative value and 24 hours postoperativelyIntraoperative supernormal oxygen delivery strategy will reduce the changes in concentration of troponin T at 24 hours postoperatively.

Secondary

MeasureTime frameDescription
blood transfusion volumeup to 24 hours postoperativelyamount of blood transfusion, amount of blood losses.
cardiac complication up to 24 hours postoperativelyup to 24 hours postoperativelyOccurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
blood pressureup to 24 hours postoperativelyInvasive arterial BP(mmHg) is measured through an arterial line at the arm.episode of hypotension (30% decrease in mean BP in relation to baseline values) and hypertension (30% increase in mean BP in relation to baseline values) will be recorded.
heart rate (HR)up to 24 hours postoperativelyHR(beats/min), bradycardia (HR \< 50 beats/min), and tachycardia (HR \> 100 beats/min) will be recorded at the same time as BP recording.
SpO2up to 24 hours postoperativelySpO2(%) and hypoxemia (SpO2 \<90%) will be recorded at the same time as BP recording.
fluid balanceup to 24hours after surgeryamount of fluids (ml) infused, amount of fluid losses
Postoperative Nausea and Vomiting (PONV)24 hours postoperativelyPostoperative Nausea and Vomiting, The incidence of PONV will be recorded using a 4-point objective score (1 = no PONV;2 = mild nausea, no vomiting; 3 = excessive nausea or vomiting;4 = vomiting ≥2 times).
length of postoperative hospital stay28 days postoperativelydays from end of surgery to hospital discharge
mortality28 days postoperativelymortality within 28 days after surgery
cardiac complication at 28 days postoperatively28 days postoperativelyOccurrence of newly diagnosed arterial fibrilation ,severe arrhythmia,clinical signs of unstable angina, myocardial infarction,pulmonary edema or therapy-requiring cardiac failure.
incidence of pulmonary infectionup to 28 days postoperativelynumber of patients having pulmonary infection requiring intravenous antibiotic therapy
Acute Kidney Injuryup to 24 hours postoperativelyperioperative and 24h postoperative urine volume, serum creatinine, blood urea nitrogen.

Other

MeasureTime frameDescription
Postoperative pain24 hours postoperativelyPostoperative pain using visual analog scale (VAS, 0-100, 0 = no pain, 100 = maximum imaginable pain) will be assessed.

Countries

China

Contacts

Primary ContactXiangcai Ruan, MD, PhD
xc_ruan@hotmail.com+8620-81048306
Backup ContactJingjing Tang
15059038216@163.com+8618898533061

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026